Home
Iovance Biotherapeutics Inc

Iovance Biotherapeutics Inc Market Share Analysis for November 2025

Iovance Biotherapeutics, Inc. is a biopharmaceutical startup based in San Carlos, California. The company works to develop tumor-infiltrating lymphocyte therapies against cancer.

Health > Biotechnology and Pharmaceuticals

Domainiovance.com

Year Founded2007

Employees501 - 1000

Annual Revenue$100M - $200M

Iovance Biotherapeutics Inc

Iovance Biotherapeutics Inc (including company regionals)

iovance.com

See more website traffic and engagement information

Iovance Biotherapeutics Inc Revenue up to November 2025 is 100M - 200M

revenue generated by Iovance Biotherapeutics Inc top domains

Iovance Biotherapeutics Inc top domains revenue over 3 years

Revenue for Iovance Biotherapeutics Inc top domains

iovance.com100M - 200M

See more with Sales Intelligence

Total visits to Iovance Biotherapeutics Inc's top domains

Understand Iovance Biotherapeutics Inc market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

iovance.com22.3K

See more with Sales Intelligence

Avg. visit duration in Iovance Biotherapeutics Inc's top domains

Analyze Iovance Biotherapeutics Inc engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

iovance.com00:01:21

See more with Sales Intelligence

Avg. pageviews on Iovance Biotherapeutics Inc's top domains

See how Iovance Biotherapeutics Inc keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

iovance.com2.19

See more with Sales Intelligence

Iovance Biotherapeutics Inc top competitors by domain

Top similar sites in November 2025, ranked by their affinity

maxcyte.comCompany NameMaxCyteEmployees51 - 200HQUnited States, Maryland, GaithersburgAnnual revenue$25M - $50MTotal visits13.1KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Iovance Biotherapeutics Inc

These are the website technologies, by industry, used by Iovance Biotherapeutics Inc top domains

Widget (3)

Twemoji

Advertising (2)

DoubleClick

Audio Video Media (2)

YouTube

Conversion & Analytics (2)

Google Analytics

More Technologies

13

See all

News & Signals from Iovance Biotherapeutics Inc

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsIovance Biotherapeutics, Inc. attends event ICE-T 2025.Lifileucel is explored in metastatic melanoma at ICE-T 2025.

NewsIovance Biotherapeutics, Inc. hired Corleen Roche as Chief Financial Officer on Jul 15th '25.SAN CARLOS, Calif., July 15, 2025 (GLOBE NEWSWIRE) - Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a commercial biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with cancer, today announced the appointment of Corleen Roche as Chief Financial Officer (CFO), effective August 6th, 2025.

NewsIovance Biotherapeutics, Inc. has issues with (iova) of a Class Action lawsuit.Levi & Korsinsky notifies shareholders of Iovance Biotherapeutics, inc.(iova) of a Class Action lawsuit and an upcoming deadline.